<DOC>
	<DOCNO>NCT02094703</DOCNO>
	<brief_summary>The efficacy Solifenacin Succinate 5 mg adjuvant therapy levofloxacin ( 500 mg ) short-term treatment reduce symptom patient symptomatic non complicate urinary tract infection female .</brief_summary>
	<brief_title>The Efficacy Solifenacin Succinate Adjuvant Therapy Urinary Tract Infection Females</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>female ( 1865 year old ) dysuria symptomatic non complicate urinary tract infection Pediatric Patients ( &lt; 18 year old ) geriatric Patients ( &gt; 65 year old ) pregnant Patients Patients complicate urinary tract infection sexually transmitted infection Patients pathological abnormality urinary bladder , include stone/mass Cathetermounted Neurological diseases/disorders patient allergy/hypersensitivity Levofloxacin/Solifenacin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>female</keyword>
	<keyword>age 18-65 year</keyword>
	<keyword>storage symptom</keyword>
	<keyword>clinical urinary tract infection</keyword>
	<keyword>non complicate</keyword>
</DOC>